Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01896518 · ClinicalTrials.gov registry record · NA
Novel Methods to Reduce Children's Secondhand Smoke Exposure II
A NA study of Secondhand Smoke, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT01896518 is a NA study of Secondhand Smoke that has completed, run by University of Oklahoma. The registered enrollment target is 74 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01896518, a NA study of Secondhand Smoke, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of the current study is to determine if the use of nicotine containing products by caregivers who smoke and who are not interested in quitting, is effective in reducing children's secondhand smoke exposure.
Conditions Studied
Interventions
- DRUG Nicotine polacrilex
- DRUG Tobacco lozenge
Study Locations (1)
Oklahoma
- The Children's Hospital at OU Medical Center - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01896518
The ClinicalTrials.gov registry entry for NCT01896518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Secondhand Smoke appearing as the primary indexed condition, and to 2 interventions - of which Nicotine polacrilex is the first listed.
NCT01896518 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01896518 about?
NCT01896518 is a clinical study titled "Novel Methods to Reduce Children's Secondhand Smoke Exposure II". The overall aim of the current study is to determine if the use of nicotine containing products by caregivers who smoke and who are not interested in quitting, is effective in reducing children's secondhand smoke exposure.
What is the current status of trial NCT01896518?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2012-11. Estimated completion is 2014-12.
What conditions does trial NCT01896518 study?
This clinical trial studies the following conditions: Secondhand Smoke.
What interventions are being tested in trial NCT01896518?
The interventions under investigation include: Nicotine polacrilex (DRUG), Tobacco lozenge (DRUG).
Who is sponsoring clinical trial NCT01896518?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01896518 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Secondhand Smoke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.